TOPIC 417: GPU-ACCELERATED 3D MONTE CARLO SPECT RECONSTRUCTION ALGORITHM FOR PERSONALIZED RADIOPHARMACEUTICAL THERAPY

主题 417：用于个性化放射药物治疗的 GPU 加速 3D MONTE CARLO SPECT 重建算法

• 批准号: 10496814
• 负责人: PAUL WICKRE
• 金额: $ 39.74万
• 依托单位: VOXIMETRY, INC.
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-15 至 2022-06-14
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10496814
• 关键词: 3-Dimensional; Adoption; Algorithms; Clinical; Code; Computer software; Contracts; Deposition; Dose; Drug Kinetics; Effectiveness; Funding; Hour; Kidney; Liver neoplasms; Lymphoma; Measures; Metastatic Prostate Cancer; Neuroendocrine Tumors; Normal tissue morphology; Outcome; Patients; Radiation; Radiopharmaceuticals; Site; Small Business Innovation Research Grant; Spleen; Statistical Data Interpretation; Testing; Tumor Tissue; Work; base; dosimetry; improved; in vivo; reconstruction; side effect; single photon emission computed tomography

Although radiopharmaceutical therapy (RPT) has worked well in patients with lymphoma, late-stage, metastatic prostate cancer, and neuroendocrine tumors, it is well known that because of variability in patient pharmacokinetics, standard dosing leads to clinical outcomes that are difficult to predict and drastically vary. However, it is possible to make RPT safer and more effective by first measuring the radiation emitted by the RPT agent in vivo using quantitative SPECT imaging and then calculating the radiation energy deposited in tumors and normal tissues using dosimetry software. A personalized RPT prescription can be derived that maximizes effectiveness and minimizes side effects. However, because commercially available SPECT reconstruction algorithms do not accurately correct for scatter, they are insufficient for determining personalized RPT prescriptions. Therefore, there is a clinically unmet need for better reconstruction algorithms which enable true quantitative SPECT imaging. The aim of this contract proposal is to build a graphics processing unit (GPU) software platform that can perform SPECT reconstruction with Monte Carlo (MC)-based scatter correction within 5 minutes, making it clinically viable. Fast and accurate GPU MC-based SPECT reconstruction (Torch Recon) will further improve the accuracy of RPT dosimetry and thereby accelerate the clinical adoption of our current SBIR-funded MC dose engine (Torch).

尽管放射性药物治疗(RPT)在淋巴瘤、晚期、转移性前列腺癌和神经内分泌肿瘤患者中效果良好，但众所周知，由于患者药代动力学的差异，标准剂量会导致难以预测的临床结果，而且差异很大。然而，通过首先使用定量SPECT成像测量RPT试剂在体内发射的辐射，然后使用剂量测量软件计算沉积在肿瘤和正常组织中的辐射能量，可以使RPT更安全和更有效。可以得出个性化的RPT处方，使疗效最大化，副作用最小化。然而，由于商业上可用的SPECT重建算法不能准确地校正散射，它们不足以确定个性化的RPT处方。因此，临床上对能够实现真正的定量SPECT成像的更好的重建算法的需求还没有得到满足。这份合同提案的目的是构建一个图形处理单元(GPU)软件平台，该平台可以在5分钟内使用基于蒙特卡罗(MC)的散射校正进行SPECT重建，使其在临床上可行。快速准确的基于GPU MC的SPECT重建(Torch Recon)将进一步提高RPT剂量测量的准确性，从而加快我们目前由SBIR资助的MC剂量引擎(Torch)的临床应用。